Laboratory Methods in the Assessment of Hereditary Hemostatic Disorders

Hematol Oncol Clin North Am. 2021 Dec;35(6):1051-1068. doi: 10.1016/j.hoc.2021.07.002. Epub 2021 Aug 12.

Abstract

In patients presenting with a suspect hereditary bleeding disorder a detailed bleeding history is first obtained. Testing proceeds in a tiered manner with platelet count, platelet morphology, platelet histogram, PFA-100, fibrinogen, prothrombin time, and activated partial thromboplastin time. More detailed testing includes von Willebrand factor, individual clotting factor assays, and platelet function testing. Next, testing for a dysfibrinogenemia, FXIII, or a fibrinolytic defect is considered. Hemostatic abnormality is not demonstrated in a fraction of patients. An approach to management in these patients, such as desmopressin or antifibrinolytic therapy, may be required and empiric use of blood component therapy is discouraged.

Keywords: Fibrinolytic system; Hemostasis; Hereditary bleeding disorders; Laboratory investigation.

Publication types

  • Review

MeSH terms

  • Blood Coagulation Disorders
  • Blood Coagulation Tests
  • Hemostatic Disorders*
  • Humans
  • Laboratories
  • Platelet Function Tests